Dr. Alkhatib is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Summary
- Dr. Yaser Alkhatib is an oncologist in Houston, TX. He received his medical degree from University of Jordan Faculty of Medicine and has been in practice 8 years. He also speaks multiple languages, including Arabic. He specializes in hematologic oncology and is experienced in multiple myeloma and lymphoma.
Education & Training
- Henry Ford Health/Henry Ford HospitalFellowship, Hematology and Medical Oncology, 2014 - 2017
- Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 2011 - 2014
- University of Jordan Faculty of MedicineClass of 2009
Certifications & Licensure
- MI State Medical License Active through 2025
- TX State Medical License 2021 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 16 citationsThe role of tyrosine kinase inhibitor "Lapatinib" in pulmonary hypertension.Yaser Alkhatib, Derar Albashaireh, Tameem Abdul Hamid Al-Aqtash, Rana Awdish
Pulmonary Pharmacology & Therapeutics. 2016-04-01 - 14 citationsClinical impact of metformin in diabetic diffuse large B-cell lymphoma patients: a case-control study.Yaser Alkhatib, Zaid Abdel Rahman, Philip Kuriakose
Leukemia & Lymphoma. 2017-05-01 - 12 citationsSideroblastic anemia secondary to zinc toxicity.Jawad Sheqwara, Yaser Alkhatib
Blood. 2013-07-18
Professional Memberships
- Member
- Member
- Member
- Member
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: